Solid Biosciences Shares Are Trading Higher After JP Morgan Upgraded the Stock From Neutral to Overweight and Raised Its Price Target From $10 to $15.
Solid Biosciences Shares Are Trading Higher After JP Morgan Upgraded the Stock From Neutral to Overweight and Raised Its Price Target From $10 to $15.
solid biosciences股票價格上漲，JP摩根將其評級由中立升級爲增持，並將價格目標從10美元上調至15美元。
Solid Biosciences Shares Are Trading Higher After JP Morgan Upgraded the Stock From Neutral to Overweight and Raised Its Price Target From $10 to $15.
solid biosciences股票價格上漲，JP摩根將其評級由中立升級爲增持，並將價格目標從10美元上調至15美元。